Welcome to our dedicated page for Neuberger Berman High Yield Strategies SEC filings (Ticker: NHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) filings page on Stock Titan is designed to organize the Fund’s regulatory information in one place, even though no specific SEC filings are listed in the current data set. As a diversified, closed-end management investment company focused on the high yield debt securities market, the Fund’s regulatory documents typically explain its investment policies, use of leverage, distribution practices and risk disclosures in more detail than brief news releases.
While the recent information available comes from press releases rather than SEC forms, those announcements reference key topics that are often discussed in formal filings, such as the Fund’s use of leverage through instruments like Mandatory Redeemable Preferred Shares and Floating Rate Senior Notes, its level distribution policy and its compliance with Section 19 of the Investment Company Act of 1940, as amended. They also include standard language noting that forward-looking statements involve risks and uncertainties related to market conditions, competition, regulation and operational factors.
On Stock Titan, when NHS regulatory filings are available from EDGAR, users can access documents such as annual and semi-annual reports or other required filings and use AI-powered tools to help interpret the information. These tools can highlight how the Fund describes its high yield debt strategy, leverage, distribution sources and risk factors, complementing what is already communicated through press releases about distributions, tender offers and leverage adjustments.
Investors interested in the Fund’s structure and policies can use this page to review its historical and future filings as they are added, alongside AI-generated explanations that summarize complex sections into more accessible language.
Form 4 highlights: On 07/17/2025, portfolio manager Chris Kocinski purchased 6,000 common shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS) at a volume-weighted average price of $7.3995 (price range $7.395-$7.41). This was an open-market “P” code transaction and no shares were sold.
Following the trade, Kocinski’s direct beneficial ownership rose to 21,000 shares. No derivative securities were involved and there were no amendments to prior filings. The transaction suggests incremental insider confidence but represents a modest dollar amount (~$44k) relative to the fund’s market capitalization.